Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/Ritonavir Dosing in HIV/TB Co-infection
NCT01138202Phase 2Completed
- Sponsor
- HIV-NAT
- Start
- Nov 2010
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lopinavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started Nov 2010; status: completed.
02
Drugs
lopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01138202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01138202.